home / stock / ctlt / ctlt news


CTLT News and Press, Catalent Inc. From 02/12/24

Stock Information

Company Name: Catalent Inc.
Stock Symbol: CTLT
Market: NYSE
Website: catalent.com

Menu

CTLT CTLT Quote CTLT Short CTLT News CTLT Articles CTLT Message Board
Get CTLT Alerts

News, Short Squeeze, Breakout and More Instantly...

CTLT - Novo Nordisk's parent eyes $7B annual investments by 2030: FT

2024-02-12 08:41:44 ET More on Novo Nordisk Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript Biotech And Pharma Diversification Pays Off Novo Nordisk: Outlook For Weight Loss Drugs In 2024 Booming weight-loss drug market to lift “pick-and-shovel...

CTLT - FTC likely to look at Catalent alternatives in review of Novo deal - report

2024-02-09 13:39:14 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript Catalent Q2 2024 Earnings Preview EU drug regulators to assess potenti...

CTLT - AstraZeneca looking to ramp up in-house production amid Catalent deal

2024-02-09 13:21:35 ET More on AstraZeneca AstraZeneca PLC (AZN) Q4 2023 Earnings Call Transcript AstraZeneca FY23 Earnings Review: It's OK To Buy Dip On Q4 Bottom Line Miss AstraZeneca PLC 2023 Q4 - Results - Earnings Call Presentation Ionis-AstraZeneca amyl...

CTLT - Catalent Non-GAAP EPS of -$0.24 misses by $0.22, revenue of $1.03B beats by $20M

2024-02-09 08:02:43 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript Catalent Q2 2024 Earnings Preview EU drug regulators to assess potenti...

CTLT - Catalent, Inc. Reports Second Quarter Fiscal 2024 Results

Q2'24 net revenue of $1.03 billion decreased 10% as reported, or 11% in constant currency (1) , compared to Q2'23. Q2'24 net revenue, excluding COVID-related revenue of ~$260 million in Q2’23 and ~$75 million in Q2’24, increased 8% compared to Q2'23. ...

CTLT - Expected US Company Earnings on Friday, February 9th, 2024

Asics Corporation ADR (ASCCY) is expected to report for quarter end 2023-12-31 W. P. Carey Inc. REIT (WPC) is expected to report $1.16 for Q4 2023 Core Scientific, Inc. (CORZQ) is expected to report for Q4 2023 Essent Group Ltd. (ESNT) is expected to report $1.59 for Q4 2023 SAAB ...

CTLT - Catalent Q2 2024 Earnings Preview

2024-02-08 11:38:41 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript EU drug regulators to assess potential impact of Catalent-Novo merger ...

CTLT - EU drug regulators to assess potential impact of Catalent-Novo merger

2024-02-07 17:43:49 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript Catalent ticks lower amid report Indiana plant may have quality issues ...

CTLT - Catalent - Novo Holdings Merger: Attractive Spread

2024-02-07 16:29:17 ET Summary We anticipate an FTC review for the Novo Holdings acquisition of Catalent, Inc. but see no grounds for blocking. Timetable risk due to regulatory approval under HSR Act. Attractive 10.2% gross spread with favourable probability of closing. ...

CTLT - Stocks with expensive valuations vs their peers - BofA

2024-02-07 13:43:49 ET More on S&P 500 Index: A Technical View Of Potential Downside For The Market Sterling Moves Back Into Previous Trading Range, But Will It Hold? The Warning Signs In The Stock Market Are Clear And Present (Technical Analysis) Stocks ...

Previous 10 Next 10